Author

Eleni M. Ladopoulou

Observed names: E. M. Ladopoulou, Eleni Ladopoulou

Institutions: National and Kapodistrian University of Athens, Alexander Fleming Biomedical Sciences Research Center

Observed institutions: National and Kapodistrian University of Athens, Alexander Fleming Biomedical Sciences Research Center

OpenAlex ID: A5034337124

Squalene Synthase Inhibitors: An Update on the Search for New Antihyperlipidemic and Antiatherosclerotic Agents

2011 · A. P. Kourounakis, M. G. Katselou, et al. · Current Medicinal Chemistry · 39

Antihyperlipidemic morpholine derivatives with antioxidant activity: An investigation of the aromatic substitution

2015 · Eleni M. Ladopoulou, Alexios N. Matralis, et al. · Bioorganic & Medicinal Chemistry · 35

New Multifunctional Di-tert-butylphenoloctahydro(pyrido/benz)oxazine Derivatives with Antioxidant, Antihyperlipidemic, and Antidiabetic Action

2013 · Eleni Ladopoulou, Alexios N. Matralis, et al. · Journal of Medicinal Chemistry · 22

“Hit” to lead optimization and chemoinformatic studies for a new series of Autotaxin inhibitors

2023 · Elli-Anna Stylianaki, Christiana Magkrioti, et al. · European Journal of Medicinal Chemistry · 6

An aerosolized dual-action autotaxin inhibitor-PPARγ agonist for the treatment of pulmonary fibrosis

2026 · Alexios N. Matralis, Elli-Anna Stylianaki, et al. · Cell Reports Medicine · 2

Selective RORα Inverse Agonism: A Novel Therapeutic Target in Idiopathic Pulmonary Fibrosis

2026 · Eleni M. Ladopoulou, Espen Schallmayer, et al. · European Respiratory Journal

Works count: 6

Citation count: 104

H-index: 4

I10-index: 3